Sailaja Puttagunta
Chief Tech/Sci/R&D Officer at ITERUM THERAPEUTICS PLC
Net worth: 15 968 $ as of 2024-03-30
Network origin in Sailaja Puttagunta first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
22
| Subsidiary | Pharmaceuticals: Major | 22 |
| Subsidiary | Pharmaceuticals: Major | 18 | |
17
| Public Company | Biotechnology | 17 |
| Public Company | Pharmaceuticals: Major | 15 | |
BiomX Ltd.
 BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Sailaja Puttagunta via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ALLERGAN, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member Corporate Officer/Principal Human Resources Officer | |
Bausch & Lomb, Inc.
 Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Medical Specialties | Director/Board Member Director/Board Member General Counsel | |
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| INCYTE CORPORATION | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Sales & Marketing Human Resources Officer Sales & Marketing | |
| PROCTER & GAMBLE COMPANY | Household/Personal Care | Corporate Officer/Principal Corporate Officer/Principal | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Human Resources Officer | |
| IMS HEALTH, INC. | Data Processing Services | Director/Board Member Corporate Officer/Principal | |
| ESPERION THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
Vicuron Pharmaceuticals LLC
 Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | Pharmaceuticals: Major | Director of Finance/CFO Chief Executive Officer President | |
Cerexa, Inc.
 Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Cerexa, Inc. develops biopharmaceutical products. It is focuses on developing, acquiring and commercializing antibiotics to treat life-threatening, hospital-based infections. Cerexa's compound PPI-0903 is a cephalosporin used in treatment for complicated skin and skin-structure infections, as well as community-acquired and hospital-acquired pneumonias. The company was founded in 2005 and is headquartered in Alameda, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| HYPERION THERAPEUTICS INC | Pharmaceuticals: Major | Chairman Director/Board Member | |
Sprout Group
 Sprout Group Investment ManagersFinance Sprout Group (Sprout) is venture capital subsidiary of Credit Suisse Private Equity LLC founded in 1969. The firm headquartered in New York. | Investment Managers | Corporate Officer/Principal Private Equity Investor | |
DuPont Pharmaceuticals Co.
 DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| University of Oxford | College/University | Graduate Degree Graduate Degree | |
MedPointe, Inc.
 MedPointe, Inc. Pharmaceuticals: MajorHealth Technology MedPointe, Inc. develops, markets, and sells therapeutics. The company's products include respiratory, allergy, central nervous system, cough/cold, and pediatric products. The company was founded by James S. Burns and Anthony H. Wild in 2001 and is headquartered in Somerset, NJ. | Pharmaceuticals: Major | Director/Board Member President General Counsel Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
| Massachusetts Institute of Technology | College/University | Graduate Degree Undergraduate Degree | |
| Trinity College Dublin | College/University | Undergraduate Degree Doctorate Degree | |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Undergraduate Degree Graduate Degree Graduate Degree Graduate Degree Undergraduate Degree Graduate Degree | |
| The Hebrew University of Jerusalem | College/University | Undergraduate Degree Graduate Degree Doctorate Degree | |
| NEOS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| Bar-Ilan University | College/University | Masters Business Admin Masters Business Admin | |
Chardan Capital Markets LLC
 Chardan Capital Markets LLC Investment Banks/BrokersFinance Chardan Capital Markets LLC is a registered broker-dealer headquartered in New York City. The firm was founded by Kerry Propper and Steve Urbach in 2003. The firm offers a range of services which include capital raising, merger and acquisition advisory, strategic advisory, equity research, corporate access and institutional trading to institutional clients. | Investment Banks/Brokers | Director of Research - Equity President | |
New Leaf Venture Partners LLC
 New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Venture Partners LLC (New Leaf Ventures) is an independent Venture Capital firm founded by Jeani Delagardelle, Philippe Chambon, Vijay Lathi, Ron Hunt, James Niedel, and Kathy LaPorte. The firm is headquartered in New York. It spun out from Sprout Group. | Investment Managers | Corporate Officer/Principal Founder | |
| SCISPARC LTD. | Pharmaceuticals: Major | Director of Finance/CFO Chief Executive Officer | |
| Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
| The College of Management Academic Studies | College/University | Undergraduate Degree Masters Business Admin | |
| The University of Chicago Booth School of Business | College/University | Masters Business Admin Masters Business Admin | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Forest Laboratories LLC
 Forest Laboratories LLC Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., Forest Laboratories LLC is a pharmaceutical company that manufactures pharmaceutical products. The private company is based in New York, NY. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
Iterum Therapeutics US Ltd.
 Iterum Therapeutics US Ltd. Pharmaceuticals: MajorHealth Technology Iterum Therapeutics US Ltd. manufactures pharmaceutical products. The company was founded in 2015 and is headquartered in Chicago, IL. | Pharmaceuticals: Major | Chief Executive Officer President | |
Iterum Therapeutics International Ltd.
 Iterum Therapeutics International Ltd. Pharmaceuticals: MajorHealth Technology Iterum Therapeutics International Ltd. engages in the development of clinical-stage pharmaceutical products. The company was founded in 2015 and is headquartered in Dublin, Ireland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Iterum Therapeutics US Holding Ltd.
 Iterum Therapeutics US Holding Ltd. Financial ConglomeratesFinance Iterum Therapeutics US Holding Ltd. operates as a clinical-stage pharmaceutical company. The company was founded in 2018 and is headquartered in Chicago, IL. | Financial Conglomerates | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Iterum Therapeutics Bermuda Ltd.
 Iterum Therapeutics Bermuda Ltd. Pharmaceuticals: MajorHealth Technology Iterum Therapeutics Bermuda Ltd. is an emerging growth company, which engages in the provision of financing activities. The company was founded on November 6, 2019 and is headquartered in Hamilton, Bermuda. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| XERIS BIOPHARMA HOLDINGS, INC. | Biotechnology | Chief Executive Officer General Counsel Investor Relations Contact President | |
| RENOVACOR, INC. | Biotechnology | Director/Board Member Director/Board Member |
Statistics
International
| United States | 40 |
| Israel | 7 |
| United Kingdom | 3 |
| Ireland | 3 |
| Bermuda | 2 |
Sectoral
| Health Technology | 29 |
| Consumer Services | 10 |
| Finance | 8 |
| Consumer Non-Durables | 3 |
| Technology Services | 2 |
Operational
| Director/Board Member | 452 |
| Corporate Officer/Principal | 193 |
| Independent Dir/Board Member | 160 |
| Chairman | 84 |
| President | 60 |
Most connected contacts
| Insiders | |
|---|---|
| Paul Sekhri | 61 |
| James Healy | 50 |
| Ambrose Bailey | 32 |
| Russell Greig | 31 |
| Uri Ben-Or | 31 |
| Brent Ahrens | 30 |
| Erez Chimovits | 30 |
| Ron Hunt | 29 |
| Dov Goldstein | 28 |
| Nicole Vitullo | 28 |
| Paul Edick | 27 |
| Mark Chin | 25 |
| Jonas Grossman | 25 |
| Richard de Schutter | 24 |
| Mohammed Malik | 24 |
- Stock Market
- Insiders
- Sailaja Puttagunta
- Company connections
